An Integrated Approach
At Savonix, we believe there is no mental health or physical health – there is just health.
Our CEO, Mylea Charvat, has a personal connection to dementia. When she was 13 years old, Mylea watched as her smart, spirited grandmother slowly began to lose her memory and her ability to care for herself. The experience profoundly shaped Mylea and laid the foundation for her life’s mission to understand the brain and how it works. Enter Savonix.
With our community of leading scientists, Savonix developed a mobile neurocognitive assessment and brain health platform. Clinically validated and used by patients, clinicians, and insurers worldwide, our platform allows end users to screen for cognitive health directly from their mobile device. Built specifically for mobile, it ensures precise reaction time within milliseconds, which guarantees more accurate cognitive data results.
With Savonix, individuals, employers, healthcare systems, researchers, and providers access accurate cognitive data in domains from attention and impulse control to different kinds of memory to assess for dementia risk. We create evidence-based clinical care plans at the touch of a button — fully customized to an individual’s healthcare needs.
Our Core Values
“I joined Savonix to create products that will improve the health and education of our users.”
Product Designer
Our Philosophy — The Fifth Vital Sign
To Savonix, cognition represents the fifth vital sign and is as important to measure regularly as blood pressure, temperature, pulse, and breathing rate. We make this possible. We provide our customers with comprehensive data and insights around brain health and lifestyle to inspire patient behavior change.
Our big vision? A world without dementia. We deliver improved classification and diagnosis of different types of dementia to ultimately drive prevention and novel therapeutics.
Leadership
Dr. Mylea Charvat
CEO & Founder
As CEO and Founder at Savonix, Mylea brings more than 15 years of experience as a clinical neuropsychologist and neuroscientist, business leader, and entrepreneur. At Savonix, Mylea drives strategy to address dementia globally with business and clinical leaders. She works as a
domain expert in digital cognitive assessment with partners from Boston University to Fortune 50 CEOs. A clinician with a business background, she was an early employee with Travelocity in the 1990s and went on to train as a clinical neuropsychologist and neuroscientist before founding Savonix in 2015.
She has authored peer review publications on mental health and neuroimaging, written for Psychology Today, TechCrunch, and the Huffington Post, and been a lecturer at Stanford University, the University of San Francisco, and San Francisco State University.
She completed her Ph.D. fellowship training in clinical psychology and neuroscience from Stanford University School of Medicine, a clinical internship at Napa State Hospital, a doctorate in clinical health psychology from Palo Alto University, and a BGS in psychology from the University of Kansas.
Pin Chin Kwok
President and Chief Business Officer
As President of Asia-Pacific at Savonix, Pin leverages more than 20 years of experience in both corporate and startup leadership roles, including the last decade spent in healthcare in Asia. She is passionate about improving health outcomes, and has a depth of experience in innovation, corporate transformation and startup scaling. She blends a strong strategic mindset, human-centered design, and commercial execution capabilities. Prior to joining Savonix, she was Innovation Director at LumenLab, MetLife's Innovation Center where she developed new solutions to improve health outcomes in chronic diseases, and she executed on new business models incorporating digital health solutions at Medtronic. Pin gained deep experience in working with deeply human challenges in social enterprise after an early career in banking at Citigroup in New York. She holds an MBA from the Haas School of Business at the University of California at Berkeley and a BS from New York University.
Jillian Kwan-Jacobs
Chief Operating Officer
Jillian's commitment to improving health outcomes was cultivated through her experiences, driving operational and financial transformation within leading health and payer systems. At Kaiser Permanente, she was responsible for unifying the national operational infrastructure of the clinical laboratories – a key enabler of diagnostic data and personalized care management. At Sensely, a digital health startup whose customers include the likes of the National Health Service in the UK and Rakuten, she led the company’s business operations functions through market expansions into Asia and the Middle East. Most recently, as Director of Operations for Sutter Health | Aetna, she oversaw the launch of a health plan product into the market. From her previous career in banking, Jillian's experience with the capital markets brings a depth of expertise in analyzing and executing investment decisions.
Jillian earned her BA in Mass Communications and her MBA, focused on Healthcare Management and Global Management, from the University of California at Berkeley. She currently resides in a leafy suburb of the Bay Area with her husband, son, and two Brussels Griffons.
Dan Kogan
Chief Technology Officer
Dan brings over 27 years of experience in software engineering to his position as Chief Technology Officer at Savonix. An avid entrepreneur, software engineer, and application architect, Dan is a seasoned professional with experience bringing new digital health products to market. Prior to joining the team in January 2018, he was CTO at Health 2.0, chief data scientist at Better Doctor, and a VP at digital health companies including Vitals and HealthGrades. He founded Information Technology which was acquired by IBM and Health World Web which was acquired by Health Grades. He has an BA in computer science from New York University.
Dr. Simon Collinson
Chief Science Officer
Simon was an early pioneer in the development of digital cognitive tools from the 1990s. He received his Doctorate in clinical medicine (Neuropsychology) at the University of Oxford, he has 25 years as a clinical neuropsychological researcher as a PI and Co PI and collaborator in research projects amounting to over $20 million and has authored over 80 scientific publications in neuropsychology. In addition to several lifetime and international research awards, Simon is a former Associate Professor of Psychology at The National University of Singapore, Honorary Clinical Neuropsychologist at National University Hospital, and a visiting scientist at the Institute of Mental Health, Singapore. He has held clinical and research positions in Australia and the United Kingdom including the University Department of Psychiatry at Oxford, Charing Cross Medical School/Imperial College School of Medicine London, and The Mental Health Research Institute of Victoria in Melbourne, Australia. He has been Senior Clinical Neuropsychologist in Neurosurgery at the Alfred Hospital and Cedar Court/Epworth Rehabilitation Hospitals in Melbourne, Australia.
Reynald Hiole
VP of Marketing
Reynald Hiole is Vice President of Marketing at Savonix, a digital neuropsychology platform that empowers patients, providers, payers, and researchers with end-to-end cognitive solutions to fight against dementia. He oversees brand, advertising, B2B and B2C marketing, digital channels, and customer engagement.
Reynald has over 20 years of marketing experience covering in-person retail experiences to online programs for demand generation. Prior to joining Savonix, he held the position of Director of Customer Engagement at the WCIRB and also worked at Blue Shield for fifteen years where he relaunched their brand, rolled out the first in-person Blue Shield retail store for health plan members, and managed the channel adoption program communications. He also branded and launched Trio, Blue Shield’s flagship healthcare plan, and drove the company-wide rebranding of all plans ahead of the ACA healthcare reform launch.
Originally from France, Reynald earned a BEPA in scientific principles for conditioning racehorses and high performing horses for professional competitions.
